Omega 3 fatty acid treatment in patients with epilepsy

Not Applicable

Completed

• Conditions: Epilepsy; Nervous System Diseases

• Registration Number: ISRCTN57643242
• Lead Sponsor: Faculty of Life Sciences and Computing, London Metropolitan University (UK)

Brief Summary

2018 results in https://pubmed.ncbi.nlm.nih.gov/30170260/ (added 10/05/2021)

Detailed Description

Not available

Study Timeline

• Study Start: 2014-08-20
• Study Completion: 2017-02-28
• Last Update Posted: 24 May 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 99

Inclusion Criteria

Patients with refractory idiopathic epilepsy, aged 17 to 50 years

Exclusion Criteria

1. Age under 17 and over 50 years
2. Other diseases in addition to epilepsy
3. Structural lesions
4. Pregnancy
5. Responsive to AED
6. Less than two seizures a month

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Complete elimination or reduction in the frequency seizures

Secondary Outcome Measures

Name	Time	Method
1. Improvements of cognition, memory, and manifestations of behavioural and psychiatric disorders 2. Modulation of clinical markers of cardiac arrhythmias; down regulation of inflammatory markers